VPS4A and neoplasm: We then explored whether patient ARD-44 harbored a deletion in either VPS4A or VPS4B. By analyzing the frequency of heterozygous mutation (15 variants) in VPS4B and its neighboring genes in tumor versus normal tissues, we concluded that the patient’s tumor exhibited a mosaic deletion of VPS4B (Supplementary Figure 3).